kwd 2131 has been researched along with terbutaline in 14 studies
| Studies (kwd 2131) | Trials (kwd 2131) | Recent Studies (post-2010) (kwd 2131) | Studies (terbutaline) | Trials (terbutaline) | Recent Studies (post-2010) (terbutaline) |
|---|---|---|---|---|---|
| 16 | 12 | 0 | 3,216 | 844 | 322 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pegelow, KO; Persson, CG; Sörenby, L; Strandberg, K | 1 |
| Hegardt, B; Löwhagen, O; Svedmyr, N | 3 |
| Svensson, G | 2 |
| Grönneberg, R; Hägermark, O; Strandberg, K | 1 |
| Pegelow, KO; Strandberg, K | 1 |
| Hegardt, B; Pauwels, R; Van Der Straeten, M | 2 |
| Arner, B; Hegardt, B | 1 |
| Nilsson, E; Ryrfeldt, A | 1 |
| Lowhagen, O | 1 |
| Granerus, G; Hegardt, B; Löwhagen, O; Svedmyr, N | 1 |
10 trial(s) available for kwd 2131 and terbutaline
| Article | Year |
|---|---|
New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
Topics: Adrenergic beta-Agonists; Adult; Aerosols; Aged; Asthma; Bronchodilator Agents; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Terbutaline | 1980 |
Histamine-induced bronchospasm. Its reproducibility and usage in clinical evaluation of the sub-threshold bronchodilating dose of a new beta-agonist, KWD 2131.
Topics: Adrenergic beta-Agonists; Adult; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Bronchodilator Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Histamine; Humans; Male; Middle Aged; Terbutaline | 1980 |
Cutaneous responses to allergen after local pretreatment with beta-adrenoceptor stimulating and blocking agents.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Allergens; Antigen-Antibody Reactions; Clinical Trials as Topic; Double-Blind Method; Humans; Hypersensitivity, Immediate; Intradermal Tests; Practolol; Prenalterol; Propranolol; Skin; Terbutaline | 1980 |
Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
Topics: Adrenergic beta-Agonists; Adult; Allergens; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Clinical Trials as Topic; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Placebos; Terbutaline | 1980 |
Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Allergens; Asthma; Bronchodilator Agents; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heart Rate; Histamine; Humans; Hypersensitivity; Male; Peak Expiratory Flow Rate; Random Allocation; Terbutaline; Tremor | 1980 |
Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction.
Topics: Adrenergic beta-Agonists; Adult; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Clinical Trials as Topic; Cromolyn Sodium; Female; Forced Expiratory Volume; Humans; Male; Random Allocation; Terbutaline | 1981 |
Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
Topics: Adrenergic beta-Agonists; Adult; Allergens; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypersensitivity; Male; Terbutaline | 1981 |
Topical treatment of seasonal allergic rhinitis with a beta-adrenoceptor stimulant (KWD 2131).
Topics: Administration, Intranasal; Adolescent; Adrenergic beta-Agonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Terbutaline | 1982 |
Therapeutic modulation of bronchial hyperreactivity.
Topics: Asthma; Bronchodilator Agents; Clinical Trials as Topic; Cromolyn Sodium; Double-Blind Method; Humans; Ketotifen; Phenanthrolines; Respiratory Hypersensitivity; Terbutaline | 1982 |
The protective property of equipotent bronchodilating doses of inhaled KWD 2131 and terbutaline against allergen-induced bronchospasm.
Topics: Administration, Intranasal; Adult; Allergens; Bronchial Provocation Tests; Bronchial Spasm; Bronchodilator Agents; Female; Forced Expiratory Volume; Histamine; Humans; Male; Terbutaline | 1982 |
4 other study(ies) available for kwd 2131 and terbutaline
| Article | Year |
|---|---|
Anti-anaphylactic and bronchodilating action of a beta-adrenoceptor stimulator, KWD 2131, in human lung tissue.
Topics: Adrenergic beta-Agonists; Allergens; Anaphylaxis; Bronchi; Bronchodilator Agents; Ethanolamines; Histamine Release; Humans; In Vitro Techniques; Isoproterenol; Lung; Pollen; Terbutaline | 1979 |
Effects of topical use of beta-adrenoceptor stimulants on nasal mucosa. Rhinomanometric evaluations in experiments with terbutaline and KWD 2131. II. Nasal provocation tests with hay fever patients in asymptomatic period.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Airway Resistance; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Manometry; Nasal Mucosa; Nasal Provocation Tests; Placebos; Pollen; Rhinitis, Allergic, Seasonal; Terbutaline | 1980 |
Lung uptake and antianaphylactic effects of KWD 2131 (a beta-adrenergic agonist) in perfused guinea-pig lungs.
Topics: Adrenergic beta-Agonists; Anaphylaxis; Animals; Guinea Pigs; Histamine Release; In Vitro Techniques; Lung; Male; Perfusion; Pulmonary Circulation; Terbutaline | 1981 |
Evaluation of immediate- and late-response inhibition of a new beta-agonist, KWD 2131, compared with terbutaline and DSCG.
Topics: Asthma; Bronchial Provocation Tests; Cromolyn Sodium; Drug Evaluation; Humans; Lung Volume Measurements; Random Allocation; Terbutaline | 1981 |